Konjac glucomannan
EFSA-authorised soluble fibre for maintaining normal blood cholesterol and, within an energy-restricted diet, contributing to weight loss.
- Evidence
- Strong evidenceGRADE certainty: High
- Typical dose
- LDL reduction: 4 g/day, split
- Time to effect
- Satiety acute
- Safety
- Has documented cautions
Evidence ratings summarise published research on Konjac glucomannan in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.
Ask about Konjac glucomannan
Interactions
Taking any medication?
Check Konjac glucomannan against it.
Why
Glucomannan (from the konjac root, Amorphophallus konjac) is a highly viscous soluble fibre with two EFSA-authorised health claims, for the maintenance of normal blood cholesterol (≥4 g/day) and for weight loss in the context of an energy-restricted diet (≥3 g/day before meals). The cholesterol effect is the stronger finding; weight loss is small (under 1 kg in a meta-analysis of RCTs) and applies only alongside an energy-restricted diet. Blood pressure did not change.
How it works
Absorbs water in the stomach to form a viscous gel, slowing gastric emptying and promoting satiety, basis of the weight-loss claim. In the small intestine, binds bile acids and slows nutrient absorption, basis of the cholesterol claim.
Expected onset · Satiety acute; LDL changes over 4–6 weeks
How to take
Dosage
LDL reduction: 4 g/day, split. Weight loss: 1 g three times daily with at least 1–2 glasses of water, taken 15–30 min before meals.
Timing
Before meals, with substantial water
On the label
Powder or capsules (not pre-formed tablets), pre-formed tablets carry choking risk. Stated glucomannan content per dose.
Studied in
Adults with mild dyslipidaemia, or those seeking adjunct satiety support during an energy-restricted diet.
Safety
Evidence
EU authorised claim: konjac glucomannan contributes to maintenance of normal blood cholesterol and, within an energy-restricted diet, to weight loss. Sood 2008 Am J Clin Nutr meta-analysis (14 RCTs, n=531): LDL cholesterol was 16 mg/dL lower than control and body weight 0.79 kg lower; blood pressure and HDL cholesterol did not change.
GRADE certainty: High — EU authorised claim
- EFSA Reg 432/2012 authorised claims, glucomannan (konjac mannan): maintenance of normal blood cholesterol; contribution to weight loss in the context of an energy-restricted diet
- Sood N et al., Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis, Am J Clin Nutr 2008
Questions people ask
Does Konjac glucomannan work?
EU authorised claim: konjac glucomannan contributes to maintenance of normal blood cholesterol and, within an energy-restricted diet, to weight loss. Sood 2008 Am J Clin Nutr meta-analysis (14 RCTs, n=531): LDL cholesterol was 16 mg/dL lower than control and body weight 0.79 kg lower; blood pressure and HDL cholesterol did not change. Certainty of the evidence: High, EU authorised claim.
How is Konjac glucomannan taken?
LDL reduction: 4 g/day, split. Weight loss: 1 g three times daily with at least 1–2 glasses of water, taken 15–30 min before meals. Timing: Before meals, with substantial water. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.
Are there interactions or cautions?
**Always with abundant water, choking and oesophageal obstruction are documented with tablets that swell in the throat**. Glucomannan tablets that pre-swell before swallowing are particularly risky. Can reduce absorption of co-administered medications. Separate by 2–4 hours. Mild GI upset (bloating, flatulence). Avoid in oesophageal stricture or known dysphagia. Documented drug and supplement interactions can be looked up in the free interaction reference.
What is the evidence based on?
Sources: EFSA Reg 432/2012 authorised claims, glucomannan (konjac mannan): maintenance of normal blood cholesterol; contribution to weight loss in the context of an energy-restricted diet; Sood N et al., Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis, Am J Clin Nutr 2008.
One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.